Advisory Shares Explained: What Angel Investors Need to Know Before a Startup's Cap Table Matters

According to Carta's H1 2024 compensation data, the median pre-seed advisor equity grant is 0.21% of fully diluted shares, down from 0.25% in prior years. Only 10% of pre-seed advisors receive 1% or more. You see a startup with an advisory board listing "industry veterans" and you think it signals traction. Sometimes it does. More often, you are looking at a cap table problem that compounds at every future funding round. Here is what angel investors need to know before they size that risk.

What Advisory Shares Actually Are

Advisory shares are equity grants issued to non-employee advisors in exchange for guidance, introductions, or domain expertise. They come as non-qualified stock options (NSOs) or restricted stock awards (RSAs). They are not SAFEs. They are not convertible notes. They are equity from day one, governed by a vesting agreement, and they dilute every other shareholder proportionally when exercised or vested.

NSOs are taxed as ordinary income when exercised, on the spread between the strike price and the fair market value at exercise. RSAs transfer ownership immediately but vest over time, making them eligible for the 83(b) election. That election must be filed with the IRS within 30 calendar days of the grant date. It allows the advisor to pay ordinary income tax on the typically near-zero value at grant rather than at each vesting event. Miss the 30-day window and every vesting event becomes a taxable income event at that quarter's 409A valuation. The window is irrevocable and incurable. Source: Cooley GO's 83(b) guide.

Market-Rate Grant Sizes by Stage

The Founder Institute's FAST Agreement, the most widely used advisor agreement template, defines equity by a 3-by-3 matrix of company stage and advisor engagement level. For a growth-stage company with a standard advisor: 0.15%. For an idea-stage company with an expert advisor: 1.0%. Those are the outer bounds. Carta's data from 50,000+ startups clusters tightly below the high end.

Current benchmarks by stage:

• Pre-seed: 0.21% median (Carta H1 2024)
• Seed: 0.12% median
• Series A: 0.05% median

Cooley GO benchmarks advisor option grants at 0.15% to 0.75% of fully diluted shares for a 24-month engagement with monthly vesting and no cliff. The spread reflects the difference between an advisor with a warm introduction and a senior executive who will actively open doors. For any grant above 0.5%, an investor has every right to ask what the advisor is specifically delivering and when.

Standard Vesting Terms

The market standard for advisor vesting is 24 months with monthly vesting and no cliff. Unlike employee option grants, which typically carry a one-year cliff, advisor agreements vest monthly from day one because the relationship is expected to deliver value early. Advisors who stop advising after three months should not vest two years of equity. Monthly vesting provides the natural correction.

Single-trigger acceleration on acquisition is standard. If the company sells before the advisor's vesting schedule completes, remaining unvested shares typically accelerate to fully vested at close. This aligns advisor incentives with exit outcomes.

Post-termination exercise windows for NSOs are longer than the standard 90-day employee window. Some advisor agreements give 12 months or longer after the relationship ends. Check this term carefully, as a short window can penalize an advisor who performed well but cannot fund an exercise at market price in a compressed timeframe.

Red Flags in Cap Table Due Diligence

The total advisory pool is your first check. Industry convention holds that all advisor equity combined should not exceed 5% of fully diluted shares. A company at seed stage with 8% allocated to advisors has almost certainly been overpromising equity to early contacts who have not yet earned it. That overage is dilution every other shareholder absorbs proportionally at every future round.

Grants above 1% deserve specific scrutiny. What is this advisor delivering that warrants ten times the typical engagement? If the founder cannot answer with specifics, the grant size is a negotiation failure, not a strategic investment.

Undocumented advisory relationships are a clear red flag. If a founder mentions a relationship with a named person but there is no signed advisory agreement, no board resolution, and no equity schedule, that advisor either has no commitment or has an undocumented verbal grant that could surface as a dispute during diligence for the next round. Both scenarios cost money to resolve.

I've reviewed cap tables with 15 to 20 advisors, each holding 0.25% to 0.5%. The math adds up to 4% to 10% in equity tied up in relationships formed at networking events and never formally reviewed. Advisors who stop advising typically do not voluntarily return unvested equity. Without a termination clause and a formal review process, those grants sit on the cap table indefinitely.

Questions Every Investor Should Ask

In any seed or Series A diligence process, pull the full advisory section of the cap table and ask the founder directly:

• What specific deliverable did each advisor commit to in their agreement?
• Has each grant been approved by the board of directors?
• Are there any verbal or undocumented agreements with advisors not on the formal cap table?
• What exercise price was set on each grant, and is it consistent with the 409A at the time of grant?
• When does each vesting schedule terminate, and what happens to unvested equity if the relationship ends?

A founder who cannot answer these questions does not have a cap table problem. They have a governance problem that will generate legal fees, renegotiation costs, and investor relations friction at every subsequent financing event.

The 83(b) Election Risk

If you refer someone to serve on a startup advisory board and they receive an RSA, the 83(b) election is time-critical. The IRS requires this election within 30 calendar days of the grant date. Not the signing date. The grant date. If the stock is worth $0.001 per share at grant and the advisor files the election, their taxable income is essentially zero. If they miss the window and the company raises at a $10 million valuation before vesting is complete, every vesting event is taxed at that higher valuation as ordinary income. The advisor's equity becomes an ongoing tax obligation, not a benefit. Make sure anyone you refer has a tax advisor review the grant agreement before they sign.

The Bottom Line

Advisory shares are not inherently a problem. The right advisor with the right grant size on the right vesting schedule is a legitimate tool for founders who need specific expertise they cannot afford to hire. The problem is lazy grant-making: blanket equity to everyone who offered a warm introduction, no documentation, no deliverables, no review process.

When you review a pre-investment cap table, pull the full advisory section. Count the grants. Calculate the total as a percentage of fully diluted shares. Ask about documentation. If the answers are sloppy, the rest of the company's governance is probably sloppy too. That is information worth having before you wire the funds.

Author Disclosure: Jeff Barnes, MBA has no personal position in any company, fund, or platform named in this article. Angel Investors Network has no current commercial relationship with any party mentioned. AIN provides marketing and education services, not investment advice. Past performance does not guarantee future results. All investments involve risk, including loss of principal.